105 related articles for article (PubMed ID: 23611984)
1. Structural analysis of HmtT and HmtN involved in the tailoring steps of himastatin biosynthesis.
Zhang H; Chen J; Wang H; Xie Y; Ju J; Yan Y; Zhang H
FEBS Lett; 2013 Jun; 587(11):1675-80. PubMed ID: 23611984
[TBL] [Abstract][Full Text] [Related]
2. Molecular characterization of the hydroxylase HmtN at 1.3 Å resolution.
Zhang H; Chen J; Zhang H
Biochem Biophys Res Commun; 2019 Aug; 516(3):1033-1038. PubMed ID: 28687492
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the 1.85 A structure of CYP154A1 from Streptomyces coelicolor A3(2) with the closely related CYP154C1 and CYPs from antibiotic biosynthetic pathways.
Podust LM; Bach H; Kim Y; Lamb DC; Arase M; Sherman DH; Kelly SL; Waterman MR
Protein Sci; 2004 Jan; 13(1):255-68. PubMed ID: 14691240
[TBL] [Abstract][Full Text] [Related]
4. Biosynthesis of himastatin: assembly line and characterization of three cytochrome P450 enzymes involved in the post-tailoring oxidative steps.
Ma J; Wang Z; Huang H; Luo M; Zuo D; Wang B; Sun A; Cheng YQ; Zhang C; Ju J
Angew Chem Int Ed Engl; 2011 Aug; 50(34):7797-802. PubMed ID: 21726028
[No Abstract] [Full Text] [Related]
5. Crystal structures of two aromatic hydroxylases involved in the early tailoring steps of angucycline biosynthesis.
Koskiniemi H; Metsä-Ketelä M; Dobritzsch D; Kallio P; Korhonen H; Mäntsälä P; Schneider G; Niemi J
J Mol Biol; 2007 Sep; 372(3):633-48. PubMed ID: 17669423
[TBL] [Abstract][Full Text] [Related]
6. Crystal Structure of Cytochrome P450 (CYP105P2) from Streptomyces peucetius and Its Conformational Changes in Response to Substrate Binding.
Lee CW; Lee JH; Rimal H; Park H; Lee JH; Oh TJ
Int J Mol Sci; 2016 May; 17(6):. PubMed ID: 27231902
[TBL] [Abstract][Full Text] [Related]
7. Chloramphenicol biosynthesis: the structure of CmlS, a flavin-dependent halogenase showing a covalent flavin-aspartate bond.
Podzelinska K; Latimer R; Bhattacharya A; Vining LC; Zechel DL; Jia Z
J Mol Biol; 2010 Mar; 397(1):316-31. PubMed ID: 20080101
[TBL] [Abstract][Full Text] [Related]
8. A three-dimensional protein model for human cytochrome P450 2D6 based on the crystal structures of P450 101, P450 102, and P450 108.
de Groot MJ; Vermeulen NP; Kramer JD; van Acker FA; Donné-Op den Kelder GM
Chem Res Toxicol; 1996; 9(7):1079-91. PubMed ID: 8902262
[TBL] [Abstract][Full Text] [Related]
9. Crystal structure of Streptomyces olivaceoviridis E-86 beta-xylanase containing xylan-binding domain.
Fujimoto Z; Kuno A; Kaneko S; Yoshida S; Kobayashi H; Kusakabe I; Mizuno H
J Mol Biol; 2000 Jul; 300(3):575-85. PubMed ID: 10884353
[TBL] [Abstract][Full Text] [Related]
10. Crystal structure of cytochrome P450 CYP105N1 from Streptomyces coelicolor, an oxidase in the coelibactin siderophore biosynthetic pathway.
Lim YR; Hong MK; Kim JK; Doan TT; Kim DH; Yun CH; Chun YJ; Kang LW; Kim D
Arch Biochem Biophys; 2012 Dec; 528(2):111-7. PubMed ID: 23000034
[TBL] [Abstract][Full Text] [Related]
11. Structural characterization of L-glutamate oxidase from Streptomyces sp. X-119-6.
Arima J; Sasaki C; Sakaguchi C; Mizuno H; Tamura T; Kashima A; Kusakabe H; Sugio S; Inagaki K
FEBS J; 2009 Jul; 276(14):3894-903. PubMed ID: 19531050
[TBL] [Abstract][Full Text] [Related]
12. Crystal structure of bacterial CYP116B5 heme domain: New insights on class VII P450s structural flexibility and peroxygenase activity.
Ciaramella A; Catucci G; Gilardi G; Di Nardo G
Int J Biol Macromol; 2019 Nov; 140():577-587. PubMed ID: 31430491
[TBL] [Abstract][Full Text] [Related]
13. Substrate selectivity of drug-metabolizing cytochrome P450s predicted from crystal structures and in silico modeling.
Dong D; Wu B; Chow D; Hu M
Drug Metab Rev; 2012 May; 44(2):192-208. PubMed ID: 22251142
[TBL] [Abstract][Full Text] [Related]
14. Structure, electronic properties and catalytic behaviour of an activity-enhancing CYP102A1 (P450(BM3)) variant.
Whitehouse CJ; Yang W; Yorke JA; Tufton HG; Ogilvie LC; Bell SG; Zhou W; Bartlam M; Rao Z; Wong LL
Dalton Trans; 2011 Oct; 40(40):10383-96. PubMed ID: 21603690
[TBL] [Abstract][Full Text] [Related]
15. The crystal structure of the amidohydrolase VinJ shows a unique hydrophobic tunnel for its interaction with polyketide substrates.
Shinohara Y; Miyanaga A; Kudo F; Eguchi T
FEBS Lett; 2014 Mar; 588(6):995-1000. PubMed ID: 24530530
[TBL] [Abstract][Full Text] [Related]
16. Crystal structure of CYP199A2, a para-substituted benzoic acid oxidizing cytochrome P450 from Rhodopseudomonas palustris.
Bell SG; Xu F; Forward I; Bartlam M; Rao Z; Wong LL
J Mol Biol; 2008 Nov; 383(3):561-74. PubMed ID: 18762195
[TBL] [Abstract][Full Text] [Related]
17. Human P450s involved in drug metabolism and the use of structural modelling for understanding substrate selectivity and binding affinity.
Lewis DF; Ito Y
Xenobiotica; 2009 Aug; 39(8):625-35. PubMed ID: 19514836
[TBL] [Abstract][Full Text] [Related]
18. Substrate selectivity of drug-metabolizing cytochrome P450s predicted from crystal structures and in silico modeling.
Dong D; Wu B
Drug Metab Rev; 2012 Feb; 44(1):1-17. PubMed ID: 22242930
[TBL] [Abstract][Full Text] [Related]
19. Structure of OxyA tei: completing our picture of the glycopeptide antibiotic producing Cytochrome P450 cascade.
Haslinger K; Cryle MJ
FEBS Lett; 2016 Feb; 590(4):571-81. PubMed ID: 26820384
[TBL] [Abstract][Full Text] [Related]
20. Azole drugs trap cytochrome P450 EryK in alternative conformational states.
Montemiglio LC; Gianni S; Vallone B; Savino C
Biochemistry; 2010 Nov; 49(43):9199-206. PubMed ID: 20845962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
